Pharmacology of Liposomal Amphotericin B: An Introduction to Preclinical and Clinical Advances for Treatment of Life-threatening Invasive Fungal Infections

Clin Infect Dis. 2019 May 2;68(Suppl 4):S241-S243. doi: 10.1093/cid/ciz091.

Authors

Thomas J Walsh¹, Russell E Lewis², Jill Adler-Moore³

Affiliations

¹ Departments of Medicine, Pediatrics, and Microbiology & Immunology, Weill Cornell Medicine of Cornell University, New York, New York.
² Unit of Infectious Diseases, Policlinico Sant'Orsola-Malpighi, Department of Medical Sciences and Surgery, University of Bologna, Italy.
³ Department of Biological Sciences, California State Polytechnic University, Pomona.

No abstract available

Keywords: LAmB; fungal infection; liposomal amphotericin B.

Publication types

Introductory Journal Article
Research Support, Non-U.S. Gov't

MeSH terms

Amphotericin B / pharmacology*
Antifungal Agents / pharmacology*
Humans
Invasive Fungal Infections / drug therapy*
Invasive Fungal Infections / microbiology

Substances

Antifungal Agents
liposomal amphotericin B
Amphotericin B